Login / Signup

Association between fatigue and sleep disturbances during treatment for pediatric acute lymphoblastic leukemia and posttreatment neurocognitive performance.

Priscilla VasquezJohanna EscalanteKimberly P RaghubarLisa S KahalleyOlga A TaylorIda Ki MooreMarilyn J HockenberryMichael E ScheurerAustin L Brown
Published in: Pediatric blood & cancer (2021)
Our findings indicate that fatigue and sleep disturbances during the first year of pediatric ALL therapy may impact long-term neurocognitive performance. Sleep and fatigue may be targets for intervention to preserve cognitive functioning in survivors.
Keyphrases
  • sleep quality
  • acute lymphoblastic leukemia
  • physical activity
  • depressive symptoms
  • randomized controlled trial
  • bipolar disorder
  • allogeneic hematopoietic stem cell transplantation
  • acute myeloid leukemia